Cancidas and graft versus host disease Patient Reports February 10, 2012
Cancidas Side Effects Report #5632933-2
Cancidas side effect was reported by a Consumer or non-health professional from GERMANY on Jan 31, 2008. Male patient, 35 years of age, was diagnosed with stem cell transplant and was treated with Cancidas. After drug was administered, patient experienced the following side effects: blood bilirubin increased, graft versus host disease. Cancidas dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Cancidas Side Effects Report #5282031-5
Cancidas side effect was reported by a Health Professional from FRANCE on Mar 21, 2007. Male patient, 61 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: graft versus host disease, mucous membrane disorder, rash maculo-papular. Cancidas dosage: unknown. During the same period patient was treated with GENTAMICIN, TEICOPLANIN, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN AND TAZOBACTAM, TERBUTALINE SULPHATE, IPRATROPIUM BROMIDE, RIFAMYCIN. Patient was hospitalized. Patient recovered.
Cancidas Side Effects Report #5286314-4
Cancidas side effect was reported by a Health Professional from FRANCE on Mar 21, 2007. Male patient, 61 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: graft versus host disease, mucous membrane disorder, rash maculo-papular. Cancidas dosage: unknown. During the same period patient was treated with GENTAMICIN, TEICOPLANIN, PIPERACILLIN, TERBUTALINE SULPHATE, IPRATROPIUM BROMIDE, RIFAMYCIN. Patient was hospitalized. Patient recovered.
Cancidas Side Effects Report #5495332-2
Cancidas side effect was reported by a Physician from FRANCE on Oct 17, 2007. Female patient, 44 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bacterial sepsis, bronchopulmonary aspergillosis, graft versus host disease, leukaemia recurrent, zygomycosis. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5526089-4
Cancidas side effect was reported by a Physician from FRANCE on Nov 12, 2007. Female patient, 44 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bacterial sepsis, bronchopulmonary aspergillosis, graft versus host disease, leukaemia recurrent, zygomycosis. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5495315-2
Cancidas side effect was reported by a Physician from FRANCE on Oct 17, 2007. Female patient, 33 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5526073-0
Cancidas side effect was reported by a Physician from FRANCE on Nov 12, 2007. Female patient, 33 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5495337-1
Cancidas side effect was reported by a Physician from FRANCE on Oct 17, 2007. Female patient, 26 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease. Cancidas dosage: unknown. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #5524130-6
Cancidas side effect was reported by a Physician from FRANCE on Nov 12, 2007. Female patient, 26 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease. Cancidas dosage: unknown. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #5495330-9
Cancidas side effect was reported by a Physician from FRANCE on Oct 17, 2007. Female patient, 24 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease, transplant failure. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5526084-5
Cancidas side effect was reported by a Physician from FRANCE on Nov 12, 2007. Female patient, 24 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease, transplant failure. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5495338-3
Cancidas side effect was reported by a Physician from FRANCE on Oct 17, 2007. Female patient, 17 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5526077-8
Cancidas side effect was reported by a Physician from FRANCE on Nov 12, 2007. Female patient, 17 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5495343-7
Cancidas side effect was reported by a Physician from FRANCE on Oct 17, 2007. Female patient, child 10 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: adenovirus infection, bronchopulmonary aspergillosis, graft versus host disease. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #5526085-7
Cancidas side effect was reported by a Physician from FRANCE on Nov 12, 2007. Female patient, child 10 years of age, was diagnosed with pyrexia and was treated with Cancidas. After drug was administered, patient experienced the following side effects: adenovirus infection, bronchopulmonary aspergillosis, condition aggravated, graft versus host disease, herpes simplex
. Cancidas dosage: unknown. Patient died.Cancidas Side Effects Report #6075706-1
Cancidas side effect was reported by a Physician from GERMANY on Feb 10, 2009. Male patient, 14 years of age, was diagnosed with fungal sepsis, prophylaxis against graft versus host disease and was treated with Cancidas. After drug was administered, patient experienced the following side effects: graft versus host disease, hepatic failure. Cancidas dosage: unknown. Patient recovered.
Cancidas Side Effects Report #6119745-0
Cancidas side effect was reported by a Physician from GERMANY on Mar 09, 2009. Male patient, 14 years of age, weighting 121.3 lb, was diagnosed with fungal infection
, sepsis
, prophylaxis against graft versus host disease and was treated with Cancidas. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, acute hepatic failure, brain herniation, coagulopathy, graft versus host disease, haemoglobin decreased, ischaemic hepatitis, lactic acidosis, platelet count abnormal. Cancidas dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, FOSFOMYCIN, PRIMAXIN. Patient was hospitalized. Patient died on 02/13/2009.Cancidas Side Effects Report #5332741-6
Cancidas side effect was reported by a Physician from ITALY on May 15, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, FLUDARABINE PHOSPHATE, ETOPOSIDE, MELPHALAN, ANTILYMPHOCYTE IMMUNOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient died.
Cancidas Side Effects Report #5337586-9
Cancidas side effect was reported by a Physician from ITALY on May 15, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, FLUDARABINE PHOSPHATE, ETOPOSIDE, MELPHALAN, ANTILYMPHOCYTE IMMUNOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient died.
Cancidas Side Effects Report #5412948-X
Cancidas side effect was reported by a Physician from ITALY on Aug 03, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B. Patient died.
Cancidas Side Effects Report #4558517-5
Cancidas side effect was reported by a Physician from on Jan 14, 2005. Female patient, 51 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: graft versus host disease. Cancidas dosage: unknown. Patient died.
Cancidas Side Effects Report #4787149-9
Cancidas side effect was reported by a Physician from FRANCE on Sept 23, 2005. Male patient, 29 years of age, weighting 176.4 lb, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: fungal infection
, graft versus host disease, sepsis
. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND. Patient was hospitalized. Patient died on 02/03/2004.Cancidas Side Effects Report #5329289-1
Cancidas side effect was reported by a Physician from FRANCE on May 08, 2007. Male patient, 32 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease, respiratory failure, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #5332289-9
Cancidas side effect was reported by a Physician from FRANCE on May 08, 2007. Male patient, 32 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease, respiratory failure, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.
Cancidas Side Effects Report #5400472-X
Cancidas side effect was reported by a Physician from FRANCE on July 20, 2007. Male patient, 32 years of age, was diagnosed with antifungal prophylaxis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, graft versus host disease, respiratory failure, systemic candida. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.
Cancidas and graft versus host disease 